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How are skeletal tissues derived from skeletal stem
cells? Here, we map bone, cartilage, and stromal
development from a population of highly pure, post-
natal skeletal stem cells (mouse skeletal stem cells,
mSSCs) to their downstream progenitors of bone,
cartilage, and stromal tissue. We then investigated
the transcriptome of the stem/progenitor cells for
unique gene-expression patterns that would indicate
potential regulators of mSSC lineage commitment.
We demonstrate that mSSC niche factors can be
potent inducers of osteogenesis, and several spe-
cific combinations of recombinant mSSC niche fac-
tors can activate mSSC genetic programs in situ,
even in nonskeletal tissues, resulting in de novo for-
mation of cartilage or bone and bonemarrow stroma.
Inducing mSSC formation with soluble factors and
subsequently regulating the mSSC niche to specify
its differentiation toward bone, cartilage, or stromal
cells could represent a paradigm shift in the thera-
peutic regeneration of skeletal tissues.INTRODUCTION
Stem cell regulation in the skeletal system, as compared to the
hematopoietic system, remains relatively unexplored. Pioneer-
ing studies by Friedenstein et al. established the presence of
colony-forming skeletogenic cells, but only recently have efforts
begun to identify and isolate bone, cartilage, and stromal pro-
genitors for rigorous functional characterization (Bianco, 2011;
Chan et al., 2013; Friedenstein et al., 1987; Me´ndez-Ferrer
et al., 2010; Morrison et al., 2006; Park et al., 2012). In addition,
the bone marrow is a favored site of prostate and breast cancer
metastasis, and the characteristics of the bone stroma support-ing metastatic stem cell niches are largely uncharted. Another
important challenge in tissue regeneration is the limited capacity
to (re)generate cartilage, which is deficient in many diseases
(e.g., osteoarthritis, connective tissue disorders) (Burr, 2004;
Kilic et al., 2014).
We hypothesized that the skeletal system follows a program
similar to that of hematopoiesis, with a multipotent stem cell
generating various lineages in a niche that regulates differentia-
tion. Thus we sought to (1) identify a multipotent skeletal stem
cell and map its relationship to its lineage-committed progeny
and (2) identify cells and factors in the skeletal stem cell niche
that regulate its activity.RESULTS
Identification of the Skeletal Stem Cell, Its Progeny, and
Their Lineage Relationships
Bone and Cartilage Are Derived from Clonal,
Lineage-Restricted Progenitors
Weused a ‘‘Rainbowmouse’’ (Ueno andWeissman, 2006) model
to evaluate clonal-lineage relationships in vivo to determine
whether mesenchymal tissues in bone—including stroma, fat,
bone, cartilage, andmuscle—share acommonprogenitor (Rinke-
vich et al., 2011) (see Experimental Procedures). To visualize
clonal patterns within all tissues, we crossed Rainbow mice with
mice harboring a tamoxifen (TMX)-inducible ubiquitously ex-
pressed Cre under the actin promoter (Actin-Cre-ERT) (Fig-
ure 1C). Six weeks after this recombinase activation, clonal
regions could be detected as uniformly labeled areas of a distinct
color (FiguresS1AandS1B).Using thissystem,weobserveclonal
regions in the bone, particularly at the growth plate, that encom-
pass bone, cartilage, and stromal tissue but not hematopoietic,
adipose, or muscle tissue at all time points studied (Figures 1A,
1C–1D, and S1D). These data indicate that bone, cartilage, and
stromal tissue are clonally derived in vivo from lineage-restricted
stem and progenitor cells that do not also give rise to muscle
and fat, at least at the time points examined (Figure S1).Cell 160, 285–298, January 15, 2015 ª2015 Elsevier Inc. 285
(legend on next page)
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Purified Cartilage, Bone, and Stromal Progenitor Cells
Are Heterogeneous and Lineage Restricted
As we had observed a high frequency of clonal regions in the
growth plate during our Rainbow clonal analysis, we isolated
cells from the femoral growth plates by enzymatic and mechan-
ical dissociation and analyzed them by fluorescence-activated
cell sorting (FACS) for differential expression of CD45, Ter-119,
Tie2, and AlphaV integrin. These surface markers correspond
to those present on hematopoietic (CD45, Ter-119), vascular
and hematopoietic (Tie2), and osteoblastic (AlphaV integrin)
cells. We found that the growth plate had a high frequency of
cells that were CD45Ter-119Tie2AlphaV+, hereafter referred
to as [AlphaV+]. Based on subsequent microarray analysis of
[AlphaV+] showing differential expression of CD105, Thy, 6C3,
and CD200, we fractionated this population into eight subpopu-
lations (Figures 1B and 1E) (Seita et al., 2012).
To evaluate the intrinsic ability of the eight subpopulations to
give rise to skeletal tissue, we isolated cells of each subpopula-
tion from the long bones, ribs, and sternum of GFP+ mice (Fig-
ure 1E) and transplanted them beneath the renal capsules of
immunodeficient mice (Figure 1H). Four weeks after transplanta-
tion, we explanted the GFP-labeled kidney grafts and processed
the tissues for histological analysis to determine developmental
outcome (Figure 1F). The eight subpopulations exhibited
different developmental fates (Figures 1F and 1G): three followed
a pattern of endochondral ossification (grafts consisting of bone,
cartilage, and marrow) (Figures 1F and 1G: populations a, e, f);
four gave rise to primarily bone with minimal cartilage and no
marrow (Figures 1F and 1G: populations b, c, d, h); and one
gave rise to predominantly cartilage with minimal bone and no
marrow (Figures 1F and 1G: population g). Unlike the eight sub-
populations of [AlphaV+], the CD45/Ter-119+ and Tie2+ subsets
did not form bone, cartilage, or stroma (Figure S4), further
emphasizing the existence of distinct progenitors of bone, carti-
lage, and stromal tissue. These results indicate that the skeleto-
genic progenitors are diverse, with distinct cell-surface marker
profiles and skeletal tissue fates, similar to the diverse hemato-
poietic progenitor cells that generate various differentiated blood
cells.Figure 1. Bone and Cartilage Are Derived from Clonal, Lineage-Restric
(A) Micrographs: 6-week-old Rainbow Actin-Cre-ERT mouse femur, following T
microscopy (left), pentachrome stain (middle), and dissection microscope (right)
(B) FACS plots: cells isolated from three different parts of the femur illustrate that [A
middle) (p < 0.001, ANOVA, n = 3). DN = double negative, negative for Thy and 6
(C) Scheme of experiment: Actin-Cre-ERT transgenic mouse was crossed with R
TMX induction on E15, P3, and postnatal week 6. Bones were harvested 6 week
(D) Graphic representation illustrating different numbers of clones present, which
Figure S1.
(E) FACS gating strategy for isolation of eight distinct skeletal tissue subpopulatio
e = mSSC, f = pre-BCSP, g = PCP, h = Thy. Representative of 50 replicates.
(F) P3 Femur stained with Movat’s pentachrome (top). Sections stained with pe
(bottom). Populations e (mSSC), f (pre-BCSP), and a (BCSP) can reconstruct en
ulations b (BLSP), c (6C3), d (HEC), and h (Thy) formed bone with minimal cartil
200 mm. Representative of 3–20 experiments.
(G) Graph depicting the percentage tissue composition (bone [yellow], marrow [re
3–20 experiments.
(H) Scheme of experiment: 20,000 cells of each subpopulation of [AlphaV+] were is
cells were then transplanted beneath the kidney capsules of recipient mice. One
See also Figures S1, S3, S4, and S6.Identification of a Postnatal Skeletal Stem Cell
We hypothesized that skeletogenesis may proceed through a
developmental hierarchy of lineage-restricted progenitors as
occurs in hematopoiesis. We observed that the [CD45Ter-
119Tie2AlphaV+Thy6C3CD105CD200+] subpopulation
generates all of the other (seven) subpopulations through a
sequence of stages both in vitro and in vivo, beginning with gen-
eration of two multipotent progenitor cell types: first, the
[CD45Ter-119Tie2AlphaV+Thy6C3CD105CD200] cell
population, hereafter referred to as the pre-BCSP (pre-bone
cartilage and stromal progenitor); and the [CD45Ter-119Tie2
AlphaV+Thy6C3CD105+] cell population, which we previously
described as the BCSP (bone, cartilage, and stromal progenitor)
(Chan et al., 2013). The [CD45Ter-119Tie2AlphaV+Thy
6C3CD105CD200+] subpopulation generates in vitro and
in vivo all of the other (seven) subpopulations in a linear fashion.
In vitro, freshly sorted cells were cultured for 25 days, at which
point they were refractionated by FACS (Figure 2A (i), Figures
2Bi and 2Bii), and subsequently transplanted beneath the renal
capsule (Figures 2Ai and 2Biii). In vivo, the purified cells were
transplanted beneath the renal capsule and explanted 1 month
later for FACS analysis (Figures 2Aii, 2Ci, and 2Cii) or immunohis-
tochemistry (Figure 2Ciii). These data demonstrate that the
[CD45Ter-119Tie2AlphaV+Thy6C3CD105CD200+] sub-
population generates all of the other (seven) subpopulations in
a linear fashion both in vitro and in vivo.
Single sorted cells from the [CD45Ter-119AlphaV+Thy
6C3CD105CD200+] subpopulation also generated all of the
other subpopulations in a linear fashion both in vitro and in vivo
(Figures 2D and 2E). In vitro: Individual [CD45Ter-
119Tie2AlphaV+Thy6C3CD105CD200+] cells were plated
and cultured for 14 days (Figure 2Ei). FACS analysis of the resul-
tant primary colonies showed that they contained clones of the
original cell and all other (seven) subpopulations of [AlphaV+]
(Figure 2Eiv:middle panel FACS plot). These colonies contained
both cartilage and bone tissue when examined by immuno-
histochemistry (Figure 2Eiii). Furthermore, when a single
freshly sorted [CD45Ter-119Tie2AlphaV+Thy6C3CD105
CD200+] cell isolated from the primary colony was again platedted Progenitors
MX induction at P3, shows clonal expansion at the growth plate. Fluorescent
. Scale bar: 500 mm. Representative of 10 replicates.
lphaV+] is most prevalent in the growth plate (uppermost horizontal panel in the
C3 surface expression.
ainbow reporter gene mouse. Cre recombination of offspring was induced by
s post-induction.
span the bone and cartilage. Representative of sections with ten mice. See also
ns obtained from the [AlphaV+] subset. a = BCSP, b = BLSP, c = 6C3, d = HEC,
ntachrome of tissue grafts following cell transplant beneath the renal capsule
tire bone, consisting of bone, cartilage, and a functional marrow cavity. Pop-
age. Population g (PCP) formed cartilage with a minimum of bone. Scale bar:
d], and cartilage [blue]) of each of the explanted grafts a to h. Representative of
olated from the long bones of GFP-labeled P3mice using FACS. Purified GFP+
month later, the grafts were explanted.
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Figure 2. Identification of the mSSC
(A) Scheme of experiment: CD200+TN [CD45
Ter-119Tie2AlphaV+Thy6C3CD105CD200+]
cells were isolated from femora of GFP+ mice at
P3. (i) Purified mSSCs were seeded and harvested
on days 0, 11, 25 for FACS analysis. On day 25
following refractionation of the cells by FACS,
20,000 cells of each subset (mSSC, BCSP, Thy,
6C3) were transplanted beneath the kidney cap-
sules of recipient mice. The grafts were explanted
1 month later. (ii) Purified GFP-labeled mSSCs
were also directly transplanted beneath the kidney
capsules of recipient mice. One month post-
transplantation, the grafts were explanted.
(B) FACS analysis of cultured mSSCs on days 0,
11, and 25 in culture (i, ii). Transplanted mSSCs
(red box) and BCSPs (green box) formed bone,
cartilage, and a marrow cavity. Thy (blue box) and
6C3 (orange box) formed bone only, without a
marrow cavity (iii). Scale bar: 500 mm (iii, upper
panel), 200 mm (iii, lower panel). Representative of
three replicates/subpopulation.
(C) (i, ii) FACS analysis of explanted kidney capsule
grafts, in which highly purified populations of GFP-
labeled [CD45Ter-119Tie2AlphaV+Thy6C3
CD105CD200+] (mSSC) cells were transplanted
beneath the kidney capsule: graft consisted of
seven downstream subpopulations (blue, red, and
orange boxes). Bright-field micrograph of pen-
tachrome-stained explant (iii, far lower left) dem-
onstrates that mSSCs are capable of generating
bone, cartilage, and marrow. Immunostained
explant (purple box, high magnification) shows
that mSSCs are capable of generating cells that
express Thy and 6C3 (iii, middle; Thy = red, 6C3 =
white). Merged image (iii, extreme right). Fluores-
cent image of GFP+ graft (iii, far upper left). Scale
bar: 500 mm (iii, upper panel), 100 mm (iii, lower
panel), 50 mm (iii). Representative of three repli-
cates per transplanted subpopulation.
(D) Scheme of experiment: Unsorted cells from the
long bones of RFP+ P3 mice served as feeder
cells. Cells from the long bones of P3 GFP+ mice
were isolated following mechanical and enzymatic
dissociation, and mSSCs were obtained following
FACS. (i) A single GFP-labeled mSSC was co-
transplanted with 5,000 RFP+ feeder cells beneath
the renal capsule of immunodeficient mice. (ii) A
single purified GFP-labeled mSSC was plated per
well of a 96-well culture dish. Following 14 days,
formed colonies were counted, harvested, and re-
sorted using FACS, and a single purified GFP-
labeled mSSC was again plated per well of a
96-well culture dish, and the assay repeated.
(E) In vitro, colony formation assays were per-
formed by plating a single mSSC in each well of a
96-well culture dish. (i) Representative micrograph
of a primary colony depicted at 14 days post-
plating. (ii) Passaging of primary colonies resulted
in the formation of secondary colonies with similar
morphologies to those of primary colonies. (iii)
Primary colonies stained positive for anti-collagen
2 (purple), anti-osteocalcin (green), and DAPI
(blue) following immunofluorescent staining. (iv) Vertical panel on right depicts FACS analysis of initial mSSC cells isolated (top), subsequent primary colony
(middle), and secondary colony cell (bottom). Scale bar: 500 mm (i, ii), 100 mm (iii). Representative of ten assays.
(F) Microscopy of explanted grafts (as per Figure 2Di). The extent of the in vivo colony formation from GFP-labeled mSSCs is outlined by a yellow broken line
(i, iii, v) or black broken line (ii, iv, vi). Clonally expanded, GFP-labeled mSSCs are seen as green cells (fluorescent image, i, iii, v). Corresponding bright-field
(legend continued on next page)
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and cultured for 14 days, the resultant secondary colony
contained clones of the original cell and all other subpopu-
lations (Figure 2Eii) on FACS analysis (Figure 2Eiv: bottom panel
FACS plot). These results demonstrate that the in vitro self-
renewal of a single [CD45Ter-119Tie2AlphaV+Thy6C3
CD105CD200+] cell maintained the skeletogenic properties
of freshly isolated [CD45Ter-119Tie2AlphaV+Thy6C3
CD105CD200+] cells. In vivo: When transplanted individually,
[CD45Ter-119Tie2AlphaV+Thy6C3CD105CD200+] cells
did not engraft efficiently beneath the renal capsule, perhaps
reflecting their need for a supportive niche. Thus, we cotrans-
planted a single GFP-labeled [CD45Ter-119Tie2AlphaV+
Thy6C3CD105CD200+] cell with 5,000 unsorted, RFP-
labeled cells isolated from the long bones to simulate a niche
(Figure 2Di). Two weeks after transplantation, we explanted the
grafts for immunohistochemical analysis. The GFP-labeled
transplanted cells (Figures 2Fi and 2Fii) differentiated into both
chondrocytes and osteocytes in vivo (Figures 2Fiv, 2Fvi, and
2Fvii), consistent with in vitro properties (Figure 2Eiii). These
data indicate that the [CD45Ter-119Tie2AlphaV+Thy
6C3CD105CD200+] population possesses definitive stem
cell-like characteristics of self-renewal and multipotency. We
therefore conclude that the [CD45Ter-119Tie2AlphaV+Thy
6C3CD105CD200+] cell population represents a mouse skel-
etal stem cell (mSSC) population in postnatal skeletal tissues
(Figure 2G), and that the seven other subpopulations of [AlphaV+]
are mSSC progeny.
Based on the analyses described above, we defined a lineage
tree of skeletal stem/progenitor cells (Figure 2G). ThemSSC initi-
ates skeletogenesis by producingahierarchyof increasingly fate-
limitedprogenitors. Themultipotent andself-renewingmSSCfirst
gives rise to multipotent progenitors, pre-BCSPs and BCSPs.
These cells then produce the following oligolineage progenitors:
pro-chondrogenic progenitors (PCPs) [CD45Ter-119Tie2
AlphaV+Thy+6C3CD105+CD200+]; the Thy subpopulation,
[CD45Ter-119Tie2AlphaV+Thy+6C3CD105+], hereafter
referred to as Thy; B cell lymphocyte stromal progenitors, BLSPs
[CD45Ter-119AlphaV+Thy+6C3CD105]; the 6C3 subpopu-
lation, [CD45Ter-119AlphaV+Thy6C3+CD105+], hereafter
referred to as 6C3; and the hepatic leukemia factor-expressing
cell, HEC [CD45Ter-119AlphaV+Thy6C3+CD105] (Fig-
ure 2G). mSSC-derived lineages include cell types that we have
previously characterized, which possess distinct hematopoietic
supportive capabilities (Chan et al., 2013) (Figures S2A and S2B).
Identification of Factors that Regulate Skeletal Stem
and Progenitor Cell Activity and Differentiation
Downstream Skeletal Progenitors Regulate mSSC
Activity
Once we had isolated the mSSC, we focused on identifying the
cells that make up the mSSC niche, the microenvironment thatmicrographs are shown (ii, iv, vi). Fluorescent imaging of transverse sections of gr
stained sections demonstrate that clonally expanded cells are fated into bone (yell
GFP or RFP cells (per cell transplanted) to bone or cartilage formation (mean ± S
(G) Schematic representation of the skeletal stem cell lineage tree. The mSSC oc
renewal and differentiation into more lineage-restricted progenitor cells (pre-BCSP
bone, cartilage, and hematopoietic supportive stroma. The immunophenotype osupports and regulates stem cell activity. We first conducted
microarray gene-expression analyses of freshly sorted mSSC/
pre-BCSP and five downstream progenitor populations [(1)
BCSP; (2) Thy; (3) 6C3; (4) BLSP; and (5) HEC] to identify recep-
tors to signaling pathways that may regulate activity of themSSC
and its progeny (Figures 3D and 3E).
To interpret the gene-expression profiles of these cells, we
used the Gene Expression Commons (Seita et al., 2012), a plat-
form that normalizesmicroarray data against a large collection of
publicly available microarray data from the National Center for
Biotechnology Information Gene Expression Omnibus. From
this analysis, it is apparent that mSSC and its progeny differen-
tially express receptors involved in transforming growth factor,
TGF (specifically bone morphogenetic protein [BMP]) and Wnt
signaling pathways, and cognate morphogens of these path-
ways, including BMP2, TGF-b3, and Wnt3a (Figures 3D and
3E). These results suggest that paracrine and/or autocrine
signaling among mSSCs and their progeny may positively regu-
late their own expansion (Figure 3F). Furthermore, single cell
RNA sequencing revealed coexpression of BMP2 and its recep-
tor (BMPR1a) in 28% of mSSCs (Figures 3A–3C and S5), sup-
porting potential for autocrine and/or paracrine signaling in the
mSSCs.
In support of transcriptional data, the addition of exogenous
recombinant BMP2 to culture media rapidly induced expansion
of isolatedmSSC, whereas supplementation of media with either
exogenous recombinant TGF-b or tumor necrosis factor alpha
(TNF-a) did not (Figures 3G and 3H). In addition, proliferation of
mSSC in vitro wasmarkedly inhibited by addition of recombinant
gremlin 2 (an antagonist of BMP2 signaling) protein to culture
media, in contrast to control. Progeny of the mSSCs express
antagonists of the BMP2 signaling pathway, such as Gremlin 2
and Noggin (Figure 3I), suggesting the presence of a potential
negative feedback mechanism to control mSSC proliferation
by more differentiated progeny. Specifically, Thy expresses
Gremlin 2, and both Thy and BLSP express Noggin. This is
consistent with Thy and BLSP subpopulations acting in a nega-
tive feedback loop to inhibit BMP2-induced proliferation of
the mSSC, further supporting a regulatory role for paracrine
signaling among mSSCs and their progeny.
Shifting Fates: Cartilage to Bone
Our next step was to comprehend signaling pathways that could
play a role in directing the differentiation of skeletal stem/progen-
itor cells. Specifically, we wished to direct osteogenesis to chon-
drogenesis, as this is directly related to a large unmet clinical
need for cartilage (Bhumiratana et al., 2014; Jo et al., 2014;
Makris et al., 2014; Mollon et al., 2013). We asked whether
mSSC-derived stroma could influence fate commitment of skel-
etal progenitor cells (Figure 2G). We observed that the skeletal
subsets with the immunophenotype [CD45Ter-119AlphaV+
Thy+6C3CD105+CD200+] (Figure 1F: population g) isolatedafts are shown (iii, v). Corresponding bright-field micrographs of pentachrome-
ow) and cartilage (blue) (iv, vi). Graph (vii) is representative of the contribution by
EM). Scale bar: 200 mm (i–vi). Representative of five transplants of each assay.
cupies the apex of this hierarchal tree and is multipotent and capable of self-
and BCSP). ThemSSCs, pre-BCSPs, and BCSPs are capable of giving rise to
f each cell is shown.
Cell 160, 285–298, January 15, 2015 ª2015 Elsevier Inc. 289
Figure 3. The mSSC Niche Is Composed of Other Skeletal-Lineage Cells
(A) Scheme of experiment: Long bones of P3 mice were harvested as previously described. The cell suspension was sorted by FACS to obtain mSSC; BCSP;
Thy+, which encompasses the PCP, Thy, and BLSP subsets; and 6C3+, which encompasses 6C3 and HEC. Cell subpopulations were prepared for single-cell
RNA sequencing.
(B) Hierarchical clustering of single-cell RNA-sequencing data demonstrates four molecularly distinct patterns of single-cell transcriptional expression between
mSSC, BCSP, Thy+, and 6C3+.
(C) Percentage transcriptional expression of morphogen (left circle in each Venn diagram), receptor (right circle in each Venn diagram), or both (overlapping
central portion of the Venn diagram) on single-cell RNA sequencing. Note that the percentage denotes the percentage of cells within each subset (mSSC, BCSP,
Thy+, and 6C3+), which express the relevant gene sequence. (Top) The patterns show the potential for paracrine (right) and autocrine (left) signaling.
(D) Gene-expression levels of Wnt-associated genes in skeletal populations as determined using the Gene Expression Commons analysis platform. The range of
transcriptional expression is illustrated by a color change as depicted on the extreme right of the figure (i.e., dark purple correlates to high expression, whereas
dark blue correlates to low expression). Heatmap shows high expression of both Wnt ligands (Wnt3a,Wnt4,Wnt5a) and receptors (Fzd5-9), demonstrating that
Wnt signaling may be actively involved in skeletal progenitor function. Fzd = frizzled receptor. These data were compiled in triplicate, with 10,000 cells of each
subset analyzed in each sample.
(E) Ligand-receptor interaction maps demonstrate that the skeletal stem/progenitor cells can act as their own niche and signal through each other to promote
skeletogenesis. Gene-expression analysis of microarray data extracted from skeletal subsets show ligands in the left column and cognate receptors in the right
column. The connecting arrows indicate possible ligand-receptor interaction pathways. Note: GDF = growth and differentiation factor, VCAM-1 = vascular cell
adhesion molecule-1. Data were compiled from triplicate samples, with 10,000 cells of each subset analyzed in each sample.
(F) Diagram illustrating potential signaling pathways influencing activity of skeletal stem/progenitor cells. Paracrine and/or autocrine signaling may occur in the
skeletal stem cell niche and regulate cell activity and maintenance.
(G) Fluorescent micrographs illustrate colony morphology of mSSCs post-culture with morphogen (BMP2/TGF-b/TNF-a) supplementation/control (right). Graph
shows the number of mSSCs present following culture for 14 days under the different conditions (left). rhBMP2 supplementation was associated with significant
amplification of the mSSC populations in vitro (bottom left) in comparison to control, nonsupplemented media (top left) (mean ± SEM, p < 0.01, t test, n = 3).
Supplementation with TGF-b or TNF-a resulted in altered colonymorphology (upper and lower right). These results show that niche signaling can influencemSSC
proliferation. Scale bar: 200 mm.
(H) Graph illustrates the effect of rhBMP2 titration on mSSC proliferation in culture (left). The effect of BMP2 was significantly greater than control at each of the
following concentrations: 50 ng/ml (mean ± SEM, p < 0.001, ANOVA), 500 ng/ml (mean ± SEM, p < 0.01, ANOVA). Phase images illustrate the colonies of cells
(legend continued on next page)
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Figure 4. Shifting Fates: Cartilage to Bone
(A) Scheme of experiment: BCSPs were isolated
from femora of GFP+ mice at P3, and PCPs were
isolated from ears/sternum of RFP+ adult mice
following mechanical and enzymatic digestion
and subsequent FACS fractionation. Purified
GFP+ BCSP and RFP+ PCP were cotransplanted
beneath the kidney capsules of immunodeficient
recipient mice. RFP+ PCP transplant served as a
control. One month after transplantation, all grafts
were removed for analysis.
(B) Microscopy of explanted grafts 1 month
following transplantation of 20,000 RFP+ PCP cells
(see Figure 4A). The white dotted line outlines the
extent of the graft formed. Fluorescence micro-
graph of explanted graft demonstrate the pres-
ence of an RFP+ graft (upper left). Corresponding
bright-field micrograph is shown in upper right
panel. Transverse section stained with Movat’s
pentachrome demonstrates that RFP-labeled PCP
cells form cartilage (blue stain) (lower right). Scale
bar: 500 mm (upper panel), 200 mm (lower panel).
Representative of four replicates.
(C) Microscopy of explanted grafts following co-
transplantation of 20,000 RFP-labeled PCP cells
with 20,000 GFP-labeled BCSPs (as detailed in
Figure 4A). The grafts, which formed, are outlined
by awhite dotted line (indicating RFP+ portion) and a yellow solid line (indicating GFP+ portion) (upper left). A corresponding bright-fieldmicrograph is shown in the
upper right panel. A transverse section stained with Movat’s pentachrome shows that both RFP-labeled PCPs and GFP-labeled BCSPs form bone (yellow stain)
(lower right). Scale bar: 500 mm (upper panel), 200 mm (lower panel). Representative of five replicates.fromRFP+mice are directed primarily toward cartilage formation
when transplanted in isolation beneath the renal capsule of
nonfluorescent mice; thus, we designated this cell the PCP (Fig-
ures 4A and 4B). However, when RFP-labeled PCPs (Figure 2G)
are cotransplanted with GFP-labeled BCSPs, they differentiate
into bone but not cartilage (Figure 4C).
Shifting Fates: Bone to Cartilage
Having observed that signaling from cotransplanted BCSP could
divert cartilage-fated cells toward bone formation, we next
sought to identify factors that could, conversely, selectively pro-
mote mSSCs to cartilage rather than bone fates. Emerging evi-
dence indicates that increased VEGF expression can spur
resting chondrocytes to re-enter a hypertrophic state and
resume endochondral ossification (Saito et al., 2010; Street
et al., 2002). Thus, we aimed to determine whether inhibition of
VEGF signaling could promote chondrogenic differentiation of
mSSCs by blocking VEGF-dependent ossification (Figure 5A).
We administered adenoviral vectors encoding a soluble ligand-
binding ectodomain (ECD) of the VEGFR1 receptor (Ad
sVEGFR1) intravenously, leading to potent systemic VEGF
antagonism (Wei et al., 2013). Adenovirus encoding a controlderived from the mSSCs (indicated by arrowhead in control, 50 pg/ml, 500 pg/m
500 mm, n = 3.
(I) Ligand-receptor interaction maps show gene-expression levels of BMP anta
increased expression of the receptors for the systemic hormones leptin and thy
progenitors Thy and BLSP (left top and bottom), which express BMP antagon
interaction graph shows that signaling through systemic hormones leptin and T
antagonism (via gremlin 2, noggin) and subsequent osteogenesis in skeletal strom
were compiled from triplicate samples, with 10,000 cells of each subset analyze
See also Figures S2 and S5.immunoglobulin IgG2a Fc domain served as control treatment.
One day later, we transplanted either intact embryonic day (E)
14.5 pre-osteogenic fetal femora or freshly sorted mSSCs under
the renal capsules of these mice and then explanted the tissue
3 weeks later (Figure 5A). The grafts from the Ad sVEGFR1-
treated mice contained predominantly cartilaginous tissue (Fig-
ure 5B, right). In contrast, the grafts from the control Ad Fc
animals evidenced endochondral ossification and formation of
a marrow cavity surrounded by cortical bone (Figure 5B, left).
These results suggest that VEGF blockade may promote chon-
drogenesis at the expense of osteogenesis (Figure 5C).
BMP Pathway Manipulation Can Induce De Novo
Formation of the mSSC in Extraskeletal Locations
We next investigated whether other tissue types contain cells
that are osteo-inducible or harbor dormant mSSCs that can be
activated to undergo osteogenesis. As we observed that
BMP2 can expand mSSC in vitro (Figures 3G and 3H), we tested
BMP2 as an agent that may induce such osteogenesis. We
placed collagen sponges containing recombinant BMP2 into
subcutaneous extraskeletal sites. Harvest of the collagen
sponges 4 weeks after placement revealed abundant osseousl, 5 ng/ml and by a broken line in 50 ng/ml and 500 ng/ml) (right). Scale bar:
gonists gremlin 2 and Noggin (right top and bottom, respectively). There is
roid-stimulating hormone (TSH) on the same subpopulations of downstream
ists. Viewing the left and right panels in unison, the ligand-cognate receptor
SH receptors may produce inhibitory signals for mSSC expansion by BMP2
al populations. Arrows illustrate the potential receptor-ligand interactions. Data
d in each sample.
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Figure 5. Shifting Fates: Bone to Cartilage
(A) Scheme of experiment: mSSCs were isolated from P3 mice as described
previously. Either intact pre-osteogenic femora isolated from E14.5 mice or
20,000 mSSCs were then transplanted beneath the kidney capsules of
recipientmicewith/without systemic inhibition of VEGF signaling. For inhibition
of VEGF signaling, adenoviral vectors encoding soluble VEGFR1 ectodomain
(Ad sVEGFR1) were delivered intravenously to the recipient mice 24 hr prior to
cell transplantation, leading to systemic release of this potent antagonist of
VEGF signaling. Ad Fc encoding an immunoglobulin Fc fragment was served
as a negative control. Grafts were explanted 3 weeks later.
292 Cell 160, 285–298, January 15, 2015 ª2015 Elsevier Inc.osteoids replete with marrow (Figures 6A–6C). Furthermore,
FACS analysis of cells within the marrow of the induced osteoids
revealed that hematopoietic stem cell (HSC) engraftment also
occurs in the osteoids (Figure 6B). By FACS analysis, we deter-
mined that mSSCs are normally not detectable or are exceed-
ingly rare in subcutaneous adipose tissue (Figure 6C, right
panel). In contrast, mSSCs are plentiful in BMP2-induced oste-
oids 10 days after implantation, whereas ossification is still pro-
ceeding (Figure 6C, left panel).
To determine whether BMP2 induced skeletal transformation
of in situ cells or migration of circulating skeletal progenitors re-
cruited from bone tissue, we used a parabiont model (Figure 6D).
We surgically fused actin-GFP transgenic mice to non-GFP con-
genic mice such that they established a shared circulatory sys-
tem (Conboy et al., 2013). Two weeks after parabiosis, after
confirmation of chimerism, we implanted collagen sponges con-
taining recombinant BMP2 into the inguinal fat pad of the non-
GFP parabiont. Ten days after implantation, we explanted the
sponge and surrounding tissue and performed mechanical and
chemical dissociation to isolate the constituent cells. We as-
sayed the contribution of the GFP-labeled cells to ectopic
bone formation in the non-GFP mouse by FACs analysis to
determine whether circulating cells contributed to ectopic
bone development. The tissue of the explants contained abun-
dant GFP-labeled cells at harvest, but GFP-labeled cells in the
graft were solely CD45+ hematopoietic cells (Figure 6D, left
panel, top and bottom) and not skeletal progenitors (Figure 6D,
FACS plots, mSSC cell population shown on far right). The skel-
etal progenitor population present in the explanted tissue was
entirely GFP negative, suggesting that circulating cells did not
contribute to BMP2-induced ectopic bone. These data indicate
that BMP2-induced osteogenesis involves local cell response
that is sufficient to induce mSSC formation in the subcutaneous
fat pads, leading to formation of ectopic bone that can support
hematopoiesis.
We next wished to determine which cell types could undergo
BMP2-mediated reprogramming to mSSC in these extraskeletal
sites. We, therefore, conducted FACS analysis of suspended
cells isolated from the kidney and the subcutaneous adipose tis-
sue and looked for markers that could distinguish cell types
common to both of these extraskeletal organs. We found that
both kidney and adipose tissue contain high numbers of Tie2
(Arai et al., 2004; De Palma et al., 2005; Heldin and Westermark,
1999). Using a specific Tie2Cre3MTMG reporter mouse, which
genetically labels cells that expressed Tie2 with GFP and other
cells with RFP, we again inserted collagen sponges containing(B) Graphic representation of the fate of themSSC/fetal bone transplants in the
presence of Ad sVEGFR1 or Ad Fc control. Cartilaginous fate is promoted in
the presence of systemic VEGF antagonism (n = 5, ANOVA, p < 0.001).
(C) Explanted grafts are shown in the first and third rows from the top of the
panel (control, Ad Fc in left panel, and Ad sVEGFR1 in the right panel).
Representative sections stained with Movat’s pentachrome are shown in the
second and fourth rows from the top of the panel (top two rows: intact fetal
bone, bottom two rows: mSSC). VEGF signaling inhibition resulted in the for-
mation of cartilage (blue stain) (right), with the Ad Fc group forming bone
(yellow stain) (left). Scale bar: 500 mm (intact fetal bone, top), 100 mm (intact
fetal bone, bottom), 500 mm (mSSC, top), 200 mm (mSSC, bottom). Repre-
sentative of five replicates per assay.
recombinant BMP2 into the inguinal fat pad and harvested
the implanted tissue 1 month later (Figure 6E). FACS analysis
revealed that BMP2-derived ossicles clearly incorporated
GFP-positive Tie2-derived osteocytes with visible canaliculi (Fig-
ure 6F, high-magnification inset) and Tie2-negative RFP-labeled
osteocytes (Figure 6F), suggesting that both Tie2-positive and
Tie2-negative lineages underwent BMP2-induced skeletal re-
programming. These data suggest that a variety of cell types
could potentially be induced by BMP2 to initiate formation
of mSSC.
Codelivery of BMP2 and VEGF Inhibitor Is Sufficient to
Induce De Novo Formation of Cartilage in Adipose
Tissue
Although bone itself possesses regenerative ability, the capacity
for regeneration in other skeletal tissue (e.g., cartilage) is very
low. As BMP2 induction could stimulate mSSC expansion and
formation (Figures 3G, 3H, and 6C), we speculated that the
mSSC-inducing capacity of BMP2 could be coupled with
VEGF blockade to direct de novo cartilage formation. To test
this possibility, we implanted BMP2-treated collagen sponges
into the adipose tissue of mice that had either been treated
24 hr earlier with intravenous Ad sVEGFR1 as in Figure 5 or
included soluble VEGFR1 ECD (50 mg) directly in the collagen
sponge (Figure 7A). Onemonth later, the tissues were explanted.
BMP2 alone generated bone tissue with a marrow cavity (Fig-
ure 7B, left panel). However, BMP2 with either systemic or local
VEGF inhibition resulted in predominant cartilage formation (Fig-
ure 7B, right panel). The induced cartilage contained a similar fre-
quency of PCPs to that seen in natural cartilage (Figure 7C). As
native adipose tissue normally does not undergo chondrogene-
sis, the induced cartilage likely derives from BMP2-induced
mSSCs that were shifted toward cartilage fate by the action of
VEGF blockade.
Translational Implications of Skeletal Stem Cell Biology
We next investigated the role of mSSCs in skeletal repair. High-
lighting their potential regenerative capabilities, we find that the
mSSC number is significantly higher in the callus of a fractured
femur than in the uninjured femur (Figures S6A and S6B). Inter-
estingly, mSSCs isolated from a fracture callus also demonstrate
enhanced osteogenic capacity (in comparison to uninjured)
in vitro (Figure S6C, left panel) and in vivo (Figure S6C, right
panel). As it is well known that irradiation results in osteopenia
and reduced fracture healing (Mitchell and Logan, 1998), we
asked whether the skeletal response to irradiation is linked to
depletion of mSSC activity. When mice were irradiated 12 hr
prior to fracture induction, we noted a significant reduction in
mSSC expansion at 1 week following fracture in comparison to
nonirradiated femora 1 week post-fracture (Figure S6D), echoing
previous observations (Galloway et al., 2009).
DISCUSSION
Identifying Postnatal Skeletal Stem/Progenitor Cells
and Defining the Lineage Tree
The mSSC lineage map we present consists of eight different
cellular subpopulations with distinct skeletogenic properties
and encompasses subpopulations that have characteristics of
described skeletogenic cell types identified by lineage tracing(Bianco, 2014, Me´ndez-Ferrer et al., 2010; Park et al., 2012;
Zhou et al., 2014). For example, the Thy subtype selectively
expresses high levels of CXCL12, leptin receptor, and nestin,
which are characteristics of CXCL12-abundant reticular cells,
leptin receptor-expressing cells (LepR+), and Nestin-expressing
mesenchymal stem cells, respectively. We also find that both
Nestin-cre- and MX1-cre-labeled populations overlap with the
mSSC population (Figure S3) (Chan et al., 2013).
Signals Controlling mSSC and Progenitor Activity
Mechanistically, mSSC expansion and self-renewal must be
tightly controlled, evidenced by the expression of numerous
cognate receptors to signaling molecules belonging to most of
the known signaling pathways, including Hedgehog, BMP,
FGF, and Notch. Both BMP2 and 4 are expressed by mSSCs
and most mSSC-derived subsets, where they likely mediate sur-
vival and expansion via both autocrine and paracrine loops.
Conversely, downstream progeny of mSSCs, such as Thy and
BLSP populations, express noggin and/or gremlin 2, which
antagonize BMP signaling. This suggests that mSSCs and
some of their progeny form a portion of their own niche, main-
taining critical levels of prosurvival factors such as BMP2 but
also controlling skeletal growth by antagonizing BMP signaling.
In addition, mSSCs are dramatically amplified in fracture callus,
implying that extrinsic signals generated in the regenerative envi-
ronment could locally activate these cells (Figure S6).
Directing Skeletal Progenitor Fate Determination from
Bone to Cartilage
Antagonistic signaling between mSSC-derived skeletal subsets
also appears to be a key mechanism in skeletal subset lineage
commitment, particularly to either a bone or cartilage fate.
When we antagonized VEGF signaling in early skeletal progeni-
tors, bone fates were inhibited in favor of cartilage fates. These
results echo previous reports, which suggest that VEGF acts
as an essential chondrogenic regulator (Carlevaro et al., 2000;
Gerber et al., 1999; Harper and Klagsbrun, 1999).
Directing Skeletal Progenitor Fate Determination from
Cartilage to Bone
Paracrine signaling among skeletal subsets may also participate
in determining bone versus cartilage formation, specifically in
favoring bone. Altered signaling in a particular subpopulation
can direct the skeletal fate of other subpopulations in the micro-
environment. It is possible that pathological conditions involving
calcification of cartilaginous tissues, such as osteoarthritis,
could stem from defects in the mSSC niche, leading to aberrant
signaling that promotes osteogenesis.
Hematopoietic and Skeletal StemCell Homeostasis May
Be Closely Related
At a transcriptional level, mSSC-generated progeny express
numerous cytokines necessary for HSC maintenance and
hematopoiesis, including Kit ligand and stromal-derived factor
(Figure S2C). We also find evidence that stem and progenitor
cells of the hematopoietic systemmay reciprocally regulate skel-
etal progenitors (Figures S2A, S2B, and S2D). We conducted
gene-expression analysis of multiple hematopoietic stem andCell 160, 285–298, January 15, 2015 ª2015 Elsevier Inc. 293
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progenitor subsets and found that hematopoietic progenitors
express myriad factors associated with skeletogenesis,
including BMP2, BMP7, and Wnt3a. As previously shown, the
cognate receptors of these factors are highly expressed by
mSSCs and their progeny (Figures 3D and 3E). Intriguingly,
although mSSC-generated progeny, such as Thy and BLSP,
selectively express receptors to circulating systemic hormones,
such as leptin and thyroid-stimulating hormone, these receptors
are not highly expressed in HSCs or hematopoietic subsets (Fig-
ure S2D; data not shown; Seita et al., 2012), thus, suggesting
that mSSC-derived stromal cells may link systemic endocrine
regulation to both skeletal and hematopoietic systems.
Altering Extraskeletal Niche Signaling to Induce
Osteogenesis and Chondrogenesis
Modulating niche signaling can stimulate tissue growth by
inducing proliferation of stem cells, as we have observed with
skeletal stem cells and as described in the hematopoietic system
(Calvi et al., 2003). Niche interactions may also play significant
roles in maintaining lineage commitment, for instance, high
levels of BMP2 signaling can dominate local adipose signaling
and re-specify resident Tie2+ and Tie2 subsets to undergo os-
teogenesis. Niche interactions can also determine the fate of the
mSSC. By implanting BMP2-treated collagen sponges in con-
cert with systemic or local application of soluble VEGF receptor,
we demonstrate that cartilage can be induced to form entirely by
manipulation of local signaling pathways in extraskeletal tissue.
Conclusion
Inducing mSSC formation with soluble factors and subsequently
regulating the mSSC niche to specify its differentiation toward
bone, cartilage, or stromal cells could represent a paradigm shift
in the therapeutic regeneration of skeletal tissues. This therapeu-
tic modality could also extend to the codependent hemato-
poietic system even when resident levels of endogenous mSSCsFigure 6. Manipulation of the BMP Pathway Can Induce De Novo Form
(A) Collagen sponges containing 3 mg of lyophilized rhBMP2 were placed into
explanted for analysis. Bright-field images of explants are shown, with renal caps
Transverse sections stained with Movat’s pentachrome demonstrate that induced
(left), 200 mm (right). Representative of five replicates.
(B) FACS analysis of cells within the induced osteoidmarrow reveals that circulatin
to that which occurs naturally in ‘‘normal’’ adult femurs (top row). Representative
(C) (Left) Following explantation of rhBMP2-laced collagen sponges at day 10
present within the graft revealed that mSSC (red box on FACS plot) and BCSP (g
(Right) In contrast, FACS analysis of adipose tissue in the absence of BMP2 does
plot). Scale bar: 500 mm. Representative of three replicates.
(D) A parabiosis model of GFP+ and non-GFP mouse shows that circulating skele
mousewas parabiosed to a non-GFPmouse. Twoweeks later, a collagen sponge
of the non-GFP mouse. Ten days later, the tissue was explanted and isolated the
The contribution of the GFP-labeled cells to ectopic bone formation in the non-GF
nonfluorescent = local cells). GFP-labeled cells contributing to the graft were sol
consistent of the skeletal progenitor population (horizontal upper panel, mSSCs
(E) (Left) Diagram of reporter gene mouse model shows that Tie2 expression lead
Scheme of experiment: In order to determine the cell types, which could unde
plemented a Tie2Cre 3 MTMG reporter mouse and placed a collagen sponge
explanted 1 month later for histological analysis.
(F) Fluorescent micrographs: BMP2-derived ossicles (yellow broken line) clearly in
RFP-labeled osteocytes. Area denoted by white oval is shown at higher magnifi
canaliculi in the presence of RFP+ Tie2 cells. Scale bar: 500 mm (left), 50 mm (righave been depleted by disease or aging. The challenge now is to
understand how intrinsic and extrinsic signals guide mSSCs to
regulate skeletal shape and patterning at the single-cell level.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are described in the Extended Experimental
Procedures.
Mice
C57BL6, Rag-2/gamma(c)KO, C57BL/6-Tg(CAG-EGFP)1Osb/J, Mx1Cre, and
mTmG were bred in our laboratory. Rosa-Tomato Red RFP and Tie2Cre mice
were obtained from Jackson. ‘‘Rainbow’’ mice were bred with mice harboring
a TMX-inducible ubiquitously expressed Cre under the promoter of the actin
gene. Mice were bred at our animal facility according to NIH guidelines. Pro-
tocols were approved by the institutional review board.
Isolation and Transplantation of Adult and Fetal Skeletal Progenitors
Skeletal tissueswere dissected from postnatal day (P) 3 GFP-labeledmice and
dissociated by mechanical and enzymatic dissociation. Total dissociated cells
were stained with fluorochrome-conjugated antibodies for fractionation by
FACS. Sorted and unsorted skeletal progenitors were then injected under
the renal capsule of immunodeficient mice.
Transcriptional Expression Profiling
Microarray analyses was performed on mSSC/pre-BCSPs, BCSPs, Thy+,
6C3+, HEC, and BLSPs. RNA was isolated, twice amplified, streptavidin-
labeled, fragmented, and hybridized to Affymetrix 430-2.0 arrays. Raw micro-
array data were submitted to Gene Expression Commons (http://gexc.
stanford.edu). Heatmaps representing fold change of gene expression were
generated in Gene Expression Commons.
Histological Analysis of Endochondral Ossification
Representative sections were stained with H&E, Movat’s modified pentach-
rome, or alizarin red stains depending on requirement.
Immunofluorescence
Briefly, specimens were treated with a blocking reagent, then probed with
monoclonal antibody at 4C overnight. Specimens were washed, probedation of the mSSCs in Extraskeletal Regions
extraskeletal sites in C57BL6 wild-type mice. One month later, the graft was
ule transplants shown above and subcutaneous transplants shown below (left).
osseous osteoids formed a marrow cavity (red stain) (right). Scale bar: 500 mm
gSlamF1-positive HSC engraftment occurs in the osteoids (bottom row) similar
of three replicates.
post-extraskeletal placement, FACS analysis of constituent cell populations
reen box on FACS plot) are readily detectable in the rhBMP2-treated explants.
not detect either mSSC (red box on FACS plot) or BCSP (green box on FACS
tal progenitor cells did not contribute to BMP2-induced ectopic bones. A GFP+
containing 3 mg of lyophilized rhBMP2was transplanted into the inguinal fat pad
constituent cell populations of the ectopic bone tissue as described previously.
P mouse was analyzed by FACS (broken red line; GFP+ = circulating cells, and
ely CD45+ hematopoietic cells (extreme left panel, broken purple line) and not
shown in red box on FACS plot). Representative of three replicates.
s to GFP expression. Tie2+ cells turn green, but Tie2 cells remain red. (Right)
rgo BMP2-mediated reprogramming to mSSCs in extraskeletal sites, we im-
containing rhBMP2 into the subcutaneous inguinal fat pad. The ossicle was
corporate both GFP+ Tie2+-derived osteocytes with visible canaliculi and Tie2
cation in the box on the extreme right, showing the presence of GFP+ Tie2+
ht). Representative of three replicates.
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Figure 7. Codelivery of BMP2 and VEGF Inhibitor Is Sufficient to Induce De Novo Formation of Cartilage in Adipose Tissue
(A) Scheme of experiment: codelivery of BMP2 and soluble VEGFR1 in adipose tissue. BMP2 and inhibition of VEGF signaling leads to cartilage formation. BMP2
alone leads to bone formation.
(B) Fate of subcutaneous collagen sponge implants containing BMP2 without (two panels on left) or with VEGF blockade (two panels on right). One month after
placement of collagen sponges, the grafts were explanted for analysis. Bright-field images of grafts (left) are shown alongside representative sections stainedwith
Movat’s pentachrome (right). The codelivery of BMP2 and sVEGFR1 resulted in the formation of blue staining cartilage (extreme right panels, top and bottom). The
result following systemic VEGF blockade is shown in the top series on the right, whereas the result of local VEGF blockade is shown in the bottom series on the
right. Scale bar (panels moving from right to left): 1 mm, 200 mm, 1 mm, 200 mm. Representative of four replicates.
(C) FACS plot analysis of the constituent cells of the induced cartilage (top horizontal panel) (experimental scheme as shown in Figure 7A) versus those of freshly
isolated cells from ear cartilage of age-matched mice (bottom horizontal panel) demonstrates that PCPs are found in similar frequency in the induced and natural
cartilage tissue. Representative of the assay performed in triplicate.
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with alexa-dye-conjugated antibodies, washed, and imaged with an inverted
microscope.
Cell Culture
Skeletal progenitors were cultured in MEMamedium with 10% FCS, 1% peni-
cillin-streptomycin under low O2 (2% atmospheric oxygen, 7.5%CO2) condi-
tions. For mSSC colony-forming assays, single cells were sorted into each
well of a 96-well plate and cultured for 2 weeks.
Parabiosis
Age- and sex-matched congenic GFP and non-GFP mice were sutured
together along the dorsal-dorsal and ventral-ventral folds of the skin flaps.
Two weeks later, blood chimerism was assessed by FACS.
In Vivo Osteo-induction with BMP2
rhBMP2 was resuspended in sterile filtered buffer and applied to a collagen
sponge. Sponge was lyophilized and transplanted subcutaneously into anes-
thetized mice.
Inhibition of VEGF Signaling
To study systemic inhibition of VEGF signaling, 109 pfu units of adenoviral vec-
tors encoding the soluble murine VEGFR1 ectodomain (Ad sVEGFR1) was
injected intravenously to the designated recipientmice 24 hr prior to transplan-
tation, leading to hepatic infection and secretion of this potent antagonist of
VEGF signaling into the circulation. For negative control, adenovirus encoding
a murine IgG2a Fc immunoglobulin fragment was used (Ad Fc). These re-
agents are described elsewhere (Wei et al., 2013).
Local VEGF inhibition: 50 mg of soluble VEGFR1 was lyophilized together
with recombinant BMP2 in a collagen sponge, which was then inserted into
subcutaneous fat.
Single-Cell RNA Sequencing
This was performed as previously described (Treutlein et al., 2014).
Mouse Femoral Fracture ± Hindlimb Irradiation
An incision was made from the groin crease to the knee of the right femur. A
medullary rod was placed via the intercondylar fossa. A bicortical transverse
mid-diaphyseal fracture was created, and the skin incision closed with nylon
sutures, and the mice received post-operative analgesia. The callus was har-
vested, and constituent cells isolated by mechanical and enzymatic dissocia-
tion and subsequent FACS fractionation. C57BL6 hindlimbs received a single
dose of 800 rads (8Gy) to bilateral hind limbs. Surgical placement of fracture
was performed 12 hr post-irradiation.
ACCESSION NUMBERS
The NIH GEO accession number for the microarray data reported in this paper
is GSE64447. Normalized data can also be accessed through Gene Expres-
sion Commons, ‘‘Public Bone Progenitors Model.’’
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
six supplemental figures and can be found with this article online at http://
dx.doi.org/10.1016/j.cell.2014.12.002.
AUTHOR CONTRIBUTIONS
C.K.F.C., I.L.W., and M.T.L. conceived the overall project strategy; C.K.F.C.,
E.Y.S., J.Y.C., D.L., A.M., R.T., J.V.-T., T.W., W.-J.L., K.S.-Y., M.T.C., O.M.,
M.T., R.U., G.G.W., and A.S.L. designed, performed, and interpreted data,
contributed to the writing and editing of manuscript, and prepared figures.
R.S., E.Y.S., and D.S. performed single-cell RNA-sequencing/analysis; J.S.
provided new algorithms for transcriptional analysis. C.K. and K.S.Y. designed
and contributed reagents for vascular signaling manipulation. I.L.W. and
M.T.L. edited the manuscript and supervised the laboratory.ACKNOWLEDGMENTS
We would like to acknowledge Seth Karten for his critical help in editing the
manuscript; Christopher Duldulao and Tejaswitha Naik for technical assis-
tance; Shirley Kantoff, Libuse Jerabek, and Terry Storm for laboratory man-
agement; AaronMcCarty, Joel Dollaga, and FelixManuel for animal care; Patty
Lovelace and Jennifer Ho in the Shared FACS Facility in the Lokey Stem Cell
Institute; Steve Quake, Norma Neff, Sopheak Sim, and Gary Mantalas for crit-
ical help while performing single-cell RNA sequencing; and Natalia Kosovilka
and Michael Eckart at Stanford PAN Facility for help with microarray analysis.
The authors would like to acknowledge ongoing support for this work: Virginia
and D.K. Ludwig Fund for Cancer Research, National Institutes of Health (NIH)
Grants U01HL099999, R01 CA86065, and R01 HL058770 (to I.L.W.); R01
DE021683, R21 DE024230, R01 DE019434, RC2 DE020771, U01 HL099776,
and R21 DE019274 (to M.T.L.); and 1R01CA158528, 1R01NS064517, and
2U01DK085527-06 (to C.J.K.); Siebel Fellowship from Thomas and Stacey
Siebel Foundation and Prostate Cancer Foundation Young Investigator Award
(to C.K.F.C.); CIRM TR1-01249, the Oak Foundation, the Hagey Laboratory for
Pediatric Regenerative Medicine, the Gunn/Olivier Research Fund, Stinehart-
Reed Fund (to M.T.L.); the Stanford Medical Scientist Training Program, NIH-
T32GM007365 (to J.Y.C.); Stanford University Transplant and Tissue
Engineering Center of Excellence Fellowship (to A.M. and R.T.); the Plastic
Surgery Foundation/Plastic Surgery Research Council Pilot Grant and the
American Society of Maxillofacial Surgeons Research Grant (to R.T.); Bur-
roughs Wellcome Career Award for Medical Scientists, K08 DK096048 01(to
K.S.Y.); Stanford Developmental Cancer Research Award (to D.S.); the Stan-
ford Medical Scientist Training Program, NIGMS training grant GM07365 (to
G.G.W.); and the Anonymous Donor Skeletal Stem Cell Research Fund (to
E.Y.S., C.K.F.C., and M.T.L.). The content is solely the responsibility of the
authors and does not necessarily represent the official views of the NIH.
Received: May 26, 2014
Revised: September 22, 2014
Accepted: November 25, 2014
Published: January 15, 2015REFERENCES
Arai, F., Hirao, A., Ohmura, M., Sato, H., Matsuoka, S., Takubo, K., Ito, K., Koh,
G.Y., and Suda, T. (2004). Tie2/angiopoietin-1 signaling regulates hematopoi-
etic stem cell quiescence in the bone marrow niche. Cell 118, 149–161.
Bhumiratana, S., Eton, R.E., Oungoulian, S.R., Wan, L.Q., Ateshian, G.A., and
Vunjak-Novakovic, G. (2014). Large, stratified, andmechanically functional hu-
man cartilage grown in vitro by mesenchymal condensation. Proc. Natl. Acad.
Sci. USA 111, 6940–6945.
Bianco, P. (2011). Bone and the hematopoietic niche: a tale of two stem cells.
Blood 117, 5281–5288.
Bianco, P. (2014). ‘‘Mesenchymal’’ stem cells. Annu. Rev. Cell Dev. Biol. 30,
677–704.
Burr, D.B. (2004). The importance of subchondral bone in the progression of
osteoarthritis. J. Rheumatol. Suppl. 70, 77–80.
Calvi, L.M., Adams, G.B., Weibrecht, K.W., Weber, J.M., Olson, D.P., Knight,
M.C., Martin, R.P., Schipani, E., Divieti, P., Bringhurst, F.R., et al. (2003). Oste-
oblastic cells regulate the haematopoietic stem cell niche. Nature 425,
841–846.
Carlevaro, M.F., Cermelli, S., Cancedda, R., andDescalzi Cancedda, F. (2000).
Vascular endothelial growth factor (VEGF) in cartilage neovascularization and
chondrocyte differentiation: auto-paracrine role during endochondral bone
formation. J. Cell Sci. 113, 59–69.
Conboy, M.J., Conboy, I.M., and Rando, T.A. (2013). Heterochronic parabi-
osis: historical perspective and methodological considerations for studies of
aging and longevity. Aging Cell 12, 525–530.
Chan, C.K., Lindau, P., Jiang,W., Chen, J.Y., Zhang, L.F., Chen, C.C., Seita, J.,
Sahoo, D., Kim, J.B., Lee, A., et al. (2013). Clonal precursor of bone, cartilage,Cell 160, 285–298, January 15, 2015 ª2015 Elsevier Inc. 297
and hematopoietic niche stromal cells. Proc. Natl. Acad. Sci. USA 110, 12643–
12648.
De Palma, M., Venneri, M.A., Galli, R., Sergi Sergi, L., Politi, L.S., Sampaolesi,
M., and Naldini, L. (2005). Tie2 identifies a hematopoietic lineage of proangio-
genic monocytes required for tumor vessel formation and a mesenchymal
population of pericyte progenitors. Cancer Cell 8, 211–226.
Friedenstein, A.J., Chailakhyan, R.K., and Gerasimov, U.V. (1987). Bone
marrow osteogenic stem cells: in vitro cultivation and transplantation in diffu-
sion chambers. Cell Tissue Kinet. 20, 263–272.
Galloway, J.L., Delgado, I., Ros, M.A., and Tabin, C.J. (2009). A reevaluation of
X-irradiation-induced phocomelia and proximodistal limb patterning. Nature
460, 400–404.
Gerber, H.P., Vu, T.H., Ryan, A.M., Kowalski, J., Werb, Z., and Ferrara, N.
(1999). VEGF couples hypertrophic cartilage remodeling, ossification and
angiogenesis during endochondral bone formation. Nat. Med. 5, 623–628.
Harper, J., and Klagsbrun, M. (1999). Cartilage to bone—angiogenesis leads
the way. Nat. Med. 5, 617–618.
Heldin, C.H., and Westermark, B. (1999). Mechanism of action and in vivo role
of platelet-derived growth factor. Physiol. Rev. 79, 1283–1316.
Jo, C.H., Lee, Y.G., Shin, W.H., Kim, H., Chai, J.W., Jeong, E.C., Kim, J.E.,
Shim, H., Shin, J.S., Shin, I.S., et al. (2014). Intra-articular injection of mesen-
chymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-
concept clinical trial. Stem Cells 32, 1254–1266.
Kilic, G., Kilic, E., Akgul, O., and Ozgocmen, S. (2014). Decreased femoral
cartilage thickness in patients with systemic sclerosis. Am. J. Med. Sci. 347,
382–386.
Makris, E.A., Gomoll, A.H., Malizos, K.N., Hu, J.C., and Athanasiou, K.A.
(2014). Repair and tissue engineering techniques for articular cartilage. Nat.
Rev. Rheumatology. Published online September 23, 2014. http://dx.doi.org/
10.1038/nrrheum.2014.157.
Me´ndez-Ferrer, S., Michurina, T.V., Ferraro, F., Mazloom, A.R., Macarthur,
B.D., Lira, S.A., Scadden, D.T., Ma’ayan, A., Enikolopov, G.N., and Frenette,
P.S. (2010). Mesenchymal and haematopoietic stem cells form a unique
bone marrow niche. Nature 466, 829–834.
Mitchell, M.J., and Logan, P.M. (1998). Radiation-induced changes in bone.
Radiographics 18, 1125–1136, quiz 1242–1243.298 Cell 160, 285–298, January 15, 2015 ª2015 Elsevier Inc.Mollon, B., Kandel, R., Chahal, J., and Theodoropoulos, J. (2013). The clinical
status of cartilage tissue regeneration in humans. Osteoarthritis and cartilage /
OARS. Osteoarthritis Research Society 21, 1824–1833.
Morrison, J.I., Lo¨o¨f, S., He, P., and Simon, A. (2006). Salamander limb regen-
eration involves the activation of a multipotent skeletal muscle satellite cell
population. J. Cell Biol. 172, 433–440.
Park, D., Spencer, J.A., Koh, B.I., Kobayashi, T., Fujisaki, J., Clemens, T.L.,
Lin, C.P., Kronenberg, H.M., and Scadden, D.T. (2012). Endogenous bone
marrow MSCs are dynamic, fate-restricted participants in bone maintenance
and regeneration. Cell Stem Cell 10, 259–272.
Rinkevich, Y., Lindau, P., Ueno, H., Longaker, M.T., andWeissman, I.L. (2011).
Germ-layer and lineage-restricted stem/progenitors regenerate the mouse
digit tip. Nature 476, 409–413.
Saito, T., Fukai, A., Mabuchi, A., Ikeda, T., Yano, F., Ohba, S., Nishida, N.,
Akune, T., Yoshimura, N., Nakagawa, T., et al. (2010). Transcriptional regula-
tion of endochondral ossification by HIF-2alpha during skeletal growth and
osteoarthritis development. Nat. Med. 16, 678–686.
Seita, J., Sahoo, D., Rossi, D.J., Bhattacharya, D., Serwold, T., Inlay, M.A.,
Ehrlich, L.I., Fathman, J.W., Dill, D.L., andWeissman, I.L. (2012). Gene Expres-
sion Commons: an open platform for absolute gene expression profiling. PLoS
ONE 7, e40321.
Street, J., Bao, M., deGuzman, L., Bunting, S., Peale, F.V., Jr., Ferrara, N.,
Steinmetz, H., Hoeffel, J., Cleland, J.L., Daugherty, A., et al. (2002). Vascular
endothelial growth factor stimulates bone repair by promoting angiogenesis
and bone turnover. Proc. Natl. Acad. Sci. USA 99, 9656–9661.
Treutlein, B., Brownfield, D.G., Wu, A.R., Neff, N.F., Mantalas, G.L., Espinoza,
F.H., Desai, T.J., Krasnow, M.A., and Quake, S.R. (2014). Reconstructing line-
age hierarchies of the distal lung epithelium using single-cell RNA-seq. Nature
509, 371–375.
Ueno, H., and Weissman, I.L. (2006). Clonal analysis of mouse development
reveals a polyclonal origin for yolk sac blood islands. Dev. Cell 11, 519–533.
Wei, K., Piecewicz, S.M., McGinnis, L.M., Taniguchi, C.M., Wiegand, S.J.,
Anderson, K., Chan, C.W., Mulligan, K.X., Kuo, D., Yuan, J., et al. (2013). A liver
Hif-2a-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by
Vegf inhibition. Nat. Med. 19, 1331–1337.
Zhou, B.O., Yue, R., Murphy, M.M., Peyer, J.G., and Morrison, S.J. (2014).
Leptin-receptor-expressing mesenchymal stromal cells represent the main
source of bone formed by adult bone marrow. Cell Stem Cell 15, 154–168.
